Haematococcus extract

MFDS public standards no.	2-27
Registered name (Korean)	헤마토코쿠스 추출물
Approval route	Notified (고시형) — listed in MFDS public standards
Daily intake (as approved)	4–12 mg

Specification (Korean original)

As written in the MFDS public standards. A product must meet these limits.

성상 Appearance	고유의 색택과 향미를 가지며 이미･이취가 없어야 함
아스타잔틴	(가) 원료성 제품 : 표시량 이상 / (나) 최종제품 : 표시량의 80~120%
아세톤(mg/kg)	30.0 이하(사용한 경우)
중금속 Heavy metals	(가) 납(mg/kg) : 1.0 이하 / (나) 카드뮴(mg/kg) : 1.0 이하 / (다) 수은(mg/kg) : 1.0 이하 / (라) 비소(mg/kg) : 1.0 이하
대장균군 Coliforms	음성

Reading the values: 이하 = or less · 이상 = or more · 음성 = negative · 불검출 = not detected · 표시량 = labelled amount · 원료성 제품 = ingredient-grade product · 최종제품 = finished product

Approved wording (Korean original)

눈의 피로도 개선에 도움을 줄 수 있음

Precautions (Korean original)

과다 섭취 시 일시적으로 피부가 황색으로 변할 수 있음 β-카로틴의 흡수를 저해할 수 있음 고시 제2026-43호(2026. 6. 11.), 시행일(2027.1.1.)

the FDA, EFSA or your national authorityRequirements differ by market. Confirm ingredient status and label wording with your own authority before importing.

Sourcing from Korea

Last synchronised: 2026-07-22

Approvals described here were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts and does not recommend any product.